Creso Pharma (ASX:CPH) share price lifts following two positive updates

It's been a tough year for shareholders of this cannabis product developer but there's good news today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price edged higher during morning trade after the company announced the launch of new e-commerce channels and its first purchase order from Poland.

The Creso share price rose by more than 8% above yesterday's close to 13 cents, before settling back to 12 cents in mid-afternoon trade.

cannabis farmer in the fields checking the crops

Image source: Getty Images

Creso expands market presence

According to the release, Creso advised it has increased its European market presence with the launch of an e-commerce channel and marketing campaign. The online platform will sell a range of new human health products designed for sport, health and wellness.

This marks the first time Creso has utilised an e-commerce platform to unlock a new potential revenue stream.

The platform underwent a special development process with input from potential customers, suppliers and consumers. It will initially target Swiss customers and then expand throughout Europe.

Switzerland represents a large addressable market of CHF 21 billion (A$31 billion) for sports-related activities.

Creso will undertake an active marketing campaign using direct mailouts and social media targeting consumers.

The company also announced that it has received its first purchase order from Poland. The company that placed the order is the Polish medical and pharmaceutical company, Polvet.

The order consists of Creso hemp flour-based, anibidiol granule product for pets, large companion animals and livestock. Valued at roughly $80,000, the products will be used in Polvet's animal clinics and distributed through established channels.

Creso head of international operations Jorge Wernli commented:

Creso Pharma's European operations continue to grow … This represents a key strategic milestone in broadening our global footprint, as well as our presence in sports and recreational markets.

We will continue to pursue growth opportunities across Europe and can now focus on both business to business and direct to consumer paths. The Company will continue to update shareholders on progress in the coming months.

About the Creso share price

This year has been challenging for Creso shareholders. The Creso share price has fallen 33% year to date and 7.7% over the past month.

Creso has a market capitalisation of approximately $144.2 million with 1.2 billion shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather unhappy hump day for the markets.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Xero and Northern Star shares

A leading expert forecasts ongoing headwinds for Xero and Northern Star shares. But why?

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
ASX Share Market News

Why Evolution Mining, Whitehaven and Santos shares are creating a buzz on Wednesday

Whitehaven, Evolution Mining and Santos shares are turning heads today. But why?

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Up 118%! Are PLS shares now a buy, hold or sell?

A leading expert provides his outlook for PLS' surging shares.

Read more »

Happy investor on tablet with finance graphs rising in overlay.
Broker Notes

Buy, hold, sell: ANZ Bank, Iress, and JB Hi-Fi shares

Here's what Morgans thinks of these shares following recent updates.

Read more »

Man looking at digital holograms of graphs, charts, and data.
ASX Share Market News

Could the AI boom just be getting started for NextDC shares?

AI is fuelling a data centre expansion, putting this ASX tech firmly in the spotlight.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Is the CSL share price in the buy zone after the biotech giant's results?

Is the biotech giant a buy following its results release?

Read more »

ASX 200 bank share trading depicted by red buy and sell dice tumbling across a sheet of data in colourful graphics
Broker Notes

With $30 billion in FY26 income, should I buy CBA shares today?

A leading analyst digs into the outlook for CBA’s slipping shares.

Read more »